Mark W. Lingen

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

Tanguy Y. Seiwert, Zhixiang Zuo, Michaela K. Keck et al. · Clinical Cancer Research · 2014 · 658 citations · Full text

Life Sciences, Genetics, Oncology +17

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

Michaela K. Keck, Zhixiang Zuo, Arun Khattri et al. · Clinical Cancer Research · 2014 · 379 citations

Medicine, Oncology, Pathology +17

Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group Trials

Richard C. Jordan, Mark W. Lingen, Bayardo Perez‐Ordoñez et al. · The American Journal of Surgical Pathology · 2012 · 377 citations · Full text

Medicine, Oncology, Molecular Diagnostics +14

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas

Mark W. Lingen, Weihong Xiao, Alessandra C. Schmitt et al. · Oral Oncology · 2012 · 349 citations · Full text

Medicine, Oncology, Oral Pathology +17

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Olga V. Volpert, William F. Ward, Mark W. Lingen et al. · Journal of Clinical Investigation · 1996 · 332 citations · Full text

Medicine, Cancer Biology, Pharmacology +12